Lijun Pang

719 total citations
25 papers, 548 citations indexed

About

Lijun Pang is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lijun Pang has authored 25 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Lijun Pang's work include Autophagy in Disease and Therapy (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Lijun Pang is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Lijun Pang collaborates with scholars based in China. Lijun Pang's co-authors include Dexi Chen, Xianghua Guo, Jiming Yin, Yabo Ouyang, Luxin Qiao, Hongbo Shi, Ronghua Jin, Yingmei Feng, Wenjing Wang and Feili Wei and has published in prestigious journals such as Clinical Infectious Diseases, Biochemical and Biophysical Research Communications and Advanced Science.

In The Last Decade

Lijun Pang

22 papers receiving 543 citations

Peers

Countries citing papers authored by Lijun Pang

Since Specialization

Citations

This map shows the geographic impact of Lijun Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Pang more than expected).

Fields of papers citing papers by Lijun Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Pang. The network helps show where Lijun Pang may publish in the future.

Co-authorship network of co-authors of Lijun Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Pang. A scholar is included among the top collaborators of Lijun Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Pang. Lijun Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study 2025 ·BMC Infectious Diseases ·Xin Zhang, (unknown), (unknown), Yuqing Sun, (unknown), Xue Chen, Lijun Pang, Yulin Zhang	0
2	Comprehensive Analysis of Uric Acid and Myasthenia Gravis: IGF1R as a Protective Factor and Potential Therapeutic Target 2025 ·CNS Neuroscience & Therapeutics ·(unknown), Lijun Pang, Han Wang, Qinghua Han, (unknown), (unknown), Ziwei Song, (unknown), Hao Chen, (unknown), Dandan Tan, (unknown), Daojun Hong	0
3	The Influential factors on clinical outcomes of focal brucellosis: A retrospective cohort study 2025 ·Acta Tropica ·Xin Zhang, (unknown), Xue Chen, (unknown), Lijun Pang, Yulin Zhang	0
4	Integrated analysis of microbiome and host transcriptome unveils correlations between lung microbiota and host immunity in bronchoalveolar lavage fluid of pneumocystis pneumonia patients 2024 ·Microbes and Infection ·Ling Zhang, Miaotian Cai, Xin Zhang, (unknown), Lijun Pang, Xue Chen, (unknown), Yuqing Sun, (unknown), (unknown), Feili Wei, Yulin Zhang	1
5	Integrative Analysis of Transcriptome and Metabolome to Illuminate the Protective Effects of Didymin against Acute Hepatic Injury 2023 ·Mediators of Inflammation ·Lijun Pang, (unknown), (unknown), Cuiyu Li, Bin Fang, Quanfang Huang, (unknown)	3
6	Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A 2022 ·European Journal of Pharmacology ·(unknown), Siyun Chen, Lijun Pang, (unknown), (unknown), (unknown), Jinbin Wei	14
7	Key technologies of rural integrated energy system with renewable energy as the main body 2022 ·Frontiers in Energy Research ·(unknown), (unknown), (unknown), Lijun Pang, Yanqing Liu, (unknown)	1
8	POU2F2‐IL‐31 Autoregulatory Circuit Converts Hepatocytes into the Origin Cells of Hepatocellular Carcinoma 2021 ·Advanced Science ·Chunwang Yuan, Lijun Pang, (unknown), Yabo Ouyang, Xianghua Guo, Kai Liu	1
9	High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients 2020 ·Cellular and Molecular Immunology ·Wenjing Wang, Bin Su, Lijun Pang, Luxin Qiao, Yingmei Feng, Yabo Ouyang, Xianghua Guo, Hongbo Shi, Feili Wei, Xiaogang Su, Jiming Yin, Ronghua Jin, Dexi Chen	99
10	The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia 2020 ·Cell Death and Disease ·Hongbo Shi, Wenjing Wang, Jiming Yin, Yabo Ouyang, Lijun Pang, Yingmei Feng, Luxin Qiao, Xianghua Guo, (unknown), Ronghua Jin, Dexi Chen	63
11	Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice 2020 ·International Immunopharmacology ·(unknown), Lijun Pang, Siyun Chen, (unknown), (unknown), Qian Qiao, (unknown), (unknown), Quanfang Huang, Xing Lin, Jinbin Wei	38
12	Asiatic acid ameliorates acute hepatic injury by reducing endoplasmic reticulum stress and triggering hepatocyte autophagy 2020 ·Biomedicine & Pharmacotherapy ·(unknown), Qian Qiao, (unknown), (unknown), Lijun Pang, Siyun Chen, Dandan Wang, (unknown), Xing Lin, Jinbin Wei	22
13	Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease 2018 ·Cell Death and Disease ·Lijun Pang, Kai Liu, Daojie Liu, Fudong Lv, Yunjin Zang, Fang Xie, Jiming Yin, Ying Shi, Yanjun Wang, Dexi Chen	46
14	Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism 2018 ·International Immunopharmacology ·Dandan Wang, (unknown), (unknown), Qian Qiao, Lijun Pang, (unknown), Facheng Bai, (unknown), Xing Lin, Jinbin Wei	40
15	AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop 2018 ·Biochemical and Biophysical Research Communications ·(unknown), Lijun Pang, Ying Shi, Wenjing Wang, Kai Liu	7
16	Overexpression of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1) induces apoptosis by promoting the transcription of caspase3 and DRAM in hepatoma cells 2018 ·Biochemical and Biophysical Research Communications ·Dongjie� Liu, Mingyang Liu, Wenjing Wang, Lijun Pang, Zhenchang Wang, Chunwang Yuan, (unknown)	34
17	Tumor-suppressing effects of autophagy on hepatocellular carcinoma 2018 ·Liver Research ·Lijun Pang, Kai Liu	7
18	Mitochondrial DNA mutations accumulated in HIV-1-infected children who have an excellent virological response when exposed to long-term antiretroviral therapy 2018 ·Journal of Antimicrobial Chemotherapy ·Yabo Ouyang, Feili Wei, Luxin Qiao, Kai Liu, (unknown), Xianghua Guo, Shanshan Wang, Lijun Pang, (unknown), Fujie Zhang, Dongdong Lin, Dexi Chen	7
19	The Δ133p53 Isoform Reduces Wtp53-induced Stimulation of DNA Pol γ Activity in the Presence and Absence of D4T 2017 ·Aging and Disease ·(unknown), (unknown), Xianghua Guo, Feili Wei, Jiming Yin, Lijun Pang, Dexi Chen	10
20	ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy 2017 ·Digestive Diseases and Sciences ·(unknown), Yuan‐Yen Chang, Fang Xie, Ying Shi, Lijun Pang, Dexi Chen	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact